350 related articles for article (PubMed ID: 19289841)
1. Selective and direct inhibition of TRPC3 channels underlies biological activities of a pyrazole compound.
Kiyonaka S; Kato K; Nishida M; Mio K; Numaga T; Sawaguchi Y; Yoshida T; Wakamori M; Mori E; Numata T; Ishii M; Takemoto H; Ojida A; Watanabe K; Uemura A; Kurose H; Morii T; Kobayashi T; Sato Y; Sato C; Hamachi I; Mori Y
Proc Natl Acad Sci U S A; 2009 Mar; 106(13):5400-5. PubMed ID: 19289841
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacological properties of novel TRPC channel inhibitors].
Kiyonaka S; Kato K; Nishida M; Mori Y
Yakugaku Zasshi; 2010 Mar; 130(3):303-11. PubMed ID: 20190514
[TBL] [Abstract][Full Text] [Related]
3. Isoproterenol-induced hypertrophy of neonatal cardiac myocytes and H9c2 cell is dependent on TRPC3-regulated Ca
Han JW; Kang C; Kim Y; Lee MG; Kim JY
Cell Calcium; 2020 Dec; 92():102305. PubMed ID: 33069962
[TBL] [Abstract][Full Text] [Related]
4. A TRPC3 blocker, ethyl-1-(4-(2,3,3-trichloroacrylamide)phenyl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate (Pyr3), prevents stent-induced arterial remodeling.
Koenig S; Schernthaner M; Maechler H; Kappe CO; Glasnov TN; Hoefler G; Braune M; Wittchow E; Groschner K
J Pharmacol Exp Ther; 2013 Jan; 344(1):33-40. PubMed ID: 23010361
[TBL] [Abstract][Full Text] [Related]
5. Regulation of canonical transient receptor potential (TRPC) channel function by diacylglycerol and protein kinase C.
Venkatachalam K; Zheng F; Gill DL
J Biol Chem; 2003 Aug; 278(31):29031-40. PubMed ID: 12721302
[TBL] [Abstract][Full Text] [Related]
6. A Selective TRPC3 Inhibitor Pyr3 Attenuates Myocardial Ischemia/Reperfusion Injury in Mice.
Lu M; Fang XX; Shi DD; Liu R; Ding Y; Zhang QF; Wang HQ; Tang JM; He XJ
Curr Med Sci; 2020 Dec; 40(6):1107-1113. PubMed ID: 33428139
[TBL] [Abstract][Full Text] [Related]
7. Differences in TRPC3 and TRPC6 channels assembly in mesenteric vascular smooth muscle cells in essential hypertension.
Álvarez-Miguel I; Cidad P; Pérez-García MT; López-López JR
J Physiol; 2017 Mar; 595(5):1497-1513. PubMed ID: 27861908
[TBL] [Abstract][Full Text] [Related]
8. Modification of phospholipase C-gamma-induced Ca2+ signal generation by 2-aminoethoxydiphenyl borate.
Ma HT; Venkatachalam K; Rys-Sikora KE; He LP; Zheng F; Gill DL
Biochem J; 2003 Dec; 376(Pt 3):667-76. PubMed ID: 14558886
[TBL] [Abstract][Full Text] [Related]
9. TRPC3 and TRPC6 are essential for angiotensin II-induced cardiac hypertrophy.
Onohara N; Nishida M; Inoue R; Kobayashi H; Sumimoto H; Sato Y; Mori Y; Nagao T; Kurose H
EMBO J; 2006 Nov; 25(22):5305-16. PubMed ID: 17082763
[TBL] [Abstract][Full Text] [Related]
10. Novel pyrazole compounds for pharmacological discrimination between receptor-operated and store-operated Ca(2+) entry pathways.
Schleifer H; Doleschal B; Lichtenegger M; Oppenrieder R; Derler I; Frischauf I; Glasnov TN; Kappe CO; Romanin C; Groschner K
Br J Pharmacol; 2012 Dec; 167(8):1712-22. PubMed ID: 22862290
[TBL] [Abstract][Full Text] [Related]
11. Expression of functional receptor-coupled TRPC3 channels in DT40 triple receptor InsP3 knockout cells.
Venkatachalam K; Ma HT; Ford DL; Gill DL
J Biol Chem; 2001 Sep; 276(36):33980-5. PubMed ID: 11466302
[TBL] [Abstract][Full Text] [Related]
12. Genetic and pharmacologic inhibition of the Ca2+ influx channel TRPC3 protects secretory epithelia from Ca2+-dependent toxicity.
Kim MS; Lee KP; Yang D; Shin DM; Abramowitz J; Kiyonaka S; Birnbaumer L; Mori Y; Muallem S
Gastroenterology; 2011 Jun; 140(7):2107-15, 2115.e1-4. PubMed ID: 21354153
[TBL] [Abstract][Full Text] [Related]
13. Pyr3 Induces Apoptosis and Inhibits Migration in Human Glioblastoma Cells.
Chang HH; Cheng YC; Tsai WC; Tsao MJ; Chen Y
Cell Physiol Biochem; 2018; 48(4):1694-1702. PubMed ID: 30078005
[TBL] [Abstract][Full Text] [Related]
14. PKC-dependent coupling of calcium permeation through transient receptor potential canonical 3 (TRPC3) to calcineurin signaling in HL-1 myocytes.
Poteser M; Schleifer H; Lichtenegger M; Schernthaner M; Stockner T; Kappe CO; Glasnov TN; Romanin C; Groschner K
Proc Natl Acad Sci U S A; 2011 Jun; 108(26):10556-61. PubMed ID: 21653882
[TBL] [Abstract][Full Text] [Related]
15. TRPC channels are necessary mediators of pathologic cardiac hypertrophy.
Wu X; Eder P; Chang B; Molkentin JD
Proc Natl Acad Sci U S A; 2010 Apr; 107(15):7000-5. PubMed ID: 20351294
[TBL] [Abstract][Full Text] [Related]
16. Pyr3, a TRPC3 channel blocker, potentiates dexamethasone sensitivity and apoptosis in acute lymphoblastic leukemia cells by disturbing Ca(2+) signaling, mitochondrial membrane potential changes and reactive oxygen species production.
Abdoul-Azize S; Buquet C; Vannier JP; Dubus I
Eur J Pharmacol; 2016 Aug; 784():90-8. PubMed ID: 27179991
[TBL] [Abstract][Full Text] [Related]
17. Transient Receptor Potential Channel Canonical Type 3 Deficiency Antagonizes Myofibroblast Transdifferentiation In Vivo.
Xia W; Wang Q; Lu Y; Hu Y; Zhang X; Zhang J; Liu D; Song J; Zhu Z; Liu D; Zhang H
Biomed Res Int; 2020; 2020():1202189. PubMed ID: 32219126
[TBL] [Abstract][Full Text] [Related]
18. Phospholipase C-dependent control of cardiac calcium homeostasis involves a TRPC3-NCX1 signaling complex.
Eder P; Probst D; Rosker C; Poteser M; Wolinski H; Kohlwein SD; Romanin C; Groschner K
Cardiovasc Res; 2007 Jan; 73(1):111-9. PubMed ID: 17129578
[TBL] [Abstract][Full Text] [Related]
19. Enhanced contractility in pregnancy is associated with augmented TRPC3, L-type, and T-type voltage-dependent calcium channel function in rat uterine radial artery.
Senadheera S; Bertrand PP; Grayson TH; Leader L; Tare M; Murphy TV; Sandow SL
Am J Physiol Regul Integr Comp Physiol; 2013 Oct; 305(8):R917-26. PubMed ID: 23948776
[TBL] [Abstract][Full Text] [Related]
20. TRPC3 channel contributes to nitric oxide release: significance during normoxia and hypoxia-reoxygenation.
Huang JH; He GW; Xue HM; Yao XQ; Liu XC; Underwood MJ; Yang Q
Cardiovasc Res; 2011 Aug; 91(3):472-82. PubMed ID: 21493700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
